Annual report [Section 13 and 15(d), not S-K Item 405]

Commitments and Contingencies - Additional Information (Details)

v3.25.1
Commitments and Contingencies - Additional Information (Details) - USD ($)
 12 Months Ended
Apr. 18, 2022
Dec. 31, 2024
Dec. 31, 2023
Sep. 30, 2024
Loss Contingencies [Line Items]        
Right-of-use asset   $ 101,437 $ 222,227  
Operating lease liabilities   110,517    
Operating Lease Expenses   141,182 141,182  
Short term lease payments   21,959 $ 22,209  
Prepaid Expenses And Other Current Assets Member        
Loss Contingencies [Line Items]        
Lease Security Deposit   $ 25,000    
Lexington [Member]        
Loss Contingencies [Line Items]        
Lease Expiration Date Sep. 30, 2025      
Operating Lease Period   9 months    
Incremental Borrowing Rate   12.00%    
Right-of-use asset   $ 101,437    
Operating lease liabilities   $ 110,517    
Lessor, Operating Lease, Description   The Office Lease contains escalating payments during the lease period. Upon execution of the Office Lease, the Company prepaid one month of rent and a security deposit, one of which will be held in escrow and credited at the termination of the lease and the other of which will be applied to the first month’s rent    
Sphaera Pharma Pte. Ltd. [Member]        
Loss Contingencies [Line Items]        
Total potential milestone payments       $ 500,000
Net sales of FDA approved drug   $ 4,400,000